MyFinsight
Home
Blog
About
Back
Income Statement
Mirum Pharmaceuticals, Inc. (MIRM)
Mirum Pharmaceuticals, Inc. (MIRM)
source: myfinsight.com
Net loss
-$67,227K
(-1047.02%↓ Y/Y)
Net loss before
provision for income taxes
-$65,538K
(-1100.55%↓ Y/Y)
Provision for income taxes
$1,689K
(320.15%↑ Y/Y)
Interest income
$3,851K
(26.97%↑ Y/Y)
Livmarli
$128,721K
(46.01%↑ Y/Y)
Bile Acid Medicines
$47,522K
(19.93%↑ Y/Y)
Loss from operations
-$42,537K
(-752.62%↓ Y/Y)
Other (expense)
income, net
-$24,234K
(-28279.07%↓ Y/Y)
Product sales, net
$176,243K
(37.92%↑ Y/Y)
Interest expense
$2,618K
(-27.05%↓ Y/Y)
Total operating
expenses
$218,780K
(64.78%↑ Y/Y)
Research and development
$90,528K
(96.51%↑ Y/Y)
Selling, general and
administrative
$81,469K
(28.73%↑ Y/Y)
Cost of sales
$30,348K
(29.58%↑ Y/Y)
Acquired in-process
research and development
$16,435K
Back